Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 98.31 | 98.31 | 0.00 |
Other | 1.76 | 1.76 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.38 | 19.78 |
Price to Book | 5.14 | 4.58 |
Price to Sales | 7.51 | 2.64 |
Price to Cash Flow | 18.21 | 17.68 |
Dividend Yield | 1.06 | 1.05 |
5 Years Earnings Growth | 8.41 | 13.95 |
Number of long holdings: 98
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 19.72 | 170.30 | -0.22% | |
Amgen | US0311621009 | 5.97 | 275.42 | -0.89% | |
Regeneron Pharma | US75886F1075 | 5.86 | 675.79 | -2.71% | |
Vertex | US92532F1003 | 5.64 | 439.62 | -0.03% | |
Alnylam | US02043Q1076 | 5.03 | 278.76 | +1.17% | |
argenx ADR | US04016X1019 | 4.46 | 648.94 | -0.50% | |
Ascendis Pharma AS | US04351P1012 | 3.40 | 128.20 | +0.56% | |
Vaxcyte | US92243G1085 | 2.32 | 89.64 | -0.38% | |
Viking Therapeutics Inc | US92686J1060 | 2.18 | 34.500 | -1.26% | |
Nuvalent Inc Class A | - | 2.10 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 619.45B | 25.00 | 8.93 | 13.09 | ||
Fidelity Contrafund | 128.94B | 35.97 | 10.77 | 15.29 | ||
Fidelity Contrafund K | 128.94B | 36.05 | 10.85 | 15.38 | ||
Fidelity Total Market Index Instl b | 104.68B | 23.88 | 7.94 | 12.50 | ||
Fidelity Blue Chip Growth | 67.04B | 39.70 | 10.19 | 18.10 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review